Ignite Creation Date:
2024-05-06 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05219266
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-06-28
First Post:
2021-10-05
Brief Title:
Managed Access Programs for PKC412 Midostaurin
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Systemic Mastocytosis With an Associated Hematologic Neoplasm |
| FMS-Like Tyrosine Kinase 3 FLT3-Mutated Acute Myeloid Leukemia |
| Acute Myeloid Leukemia |
| Aggressive Systemic Mastocytosis |
| Mast Cell Leukemia |